Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States

IMPORTANCE: Pregnant people are at high risk for severe COVID-19 but were excluded from mRNA vaccine trials; data on COVID-19 vaccine effectiveness (VE) are needed. OBJECTIVE: To evaluate the estimated effectiveness of mRNA vaccination against medically attended COVID-19 among pregnant people during...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrag, Stephanie J., Verani, Jennifer R., Dixon, Brian E., Page, Jessica M., Butterfield, Kristen A., Gaglani, Manjusha, Vazquez-Benitez, Gabriela, Zerbo, Ousseny, Natarajan, Karthik, Ong, Toan C., Lazariu, Victoria, Rao, Suchitra, Beaver, Ryan, Ellington, Sascha R., Klein, Nicola P., Irving, Stephanie A., Grannis, Shaun J., Kiduko, Salome, Barron, Michelle A., Midturi, John, Dickerson, Monica, Lewis, Ned, Stockwell, Melissa S., Stenehjem, Edward, Fadel, William F., Link-Gelles, Ruth, Murthy, Kempapura, Goddard, Kristin, Grisel, Nancy, Valvi, Nimish R., Fireman, Bruce, Arndorfer, Julie, Konatham, Deepika, Ball, Sarah, Thompson, Mark G., Naleway, Allison L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513651/
https://www.ncbi.nlm.nih.gov/pubmed/36156146
http://dx.doi.org/10.1001/jamanetworkopen.2022.33273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513651/
https://www.ncbi.nlm.nih.gov/pubmed/36156146
http://dx.doi.org/10.1001/jamanetworkopen.2022.33273

Ejemplares similares